EBV-specific cytokine-secreting TCR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-specific cytokine-secreting TCR-T cells, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma [Phase 1, Phase 2]